Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
WPRT
10351
Westport Fuel Systems
WPRT
$35.3M
| $166K | ﹤0.01% |
36,117
+19,463
| +117% | +$109K |
2019 Q4
19 quarters
|
|
10352
CALL
ARKO Corp
ARKO
$462M
| $166K | ﹤0.01% |
23,600
+20,000
| +556% | +$126K |
2023 Q3
4 quarters
|
|
10353
Aveanna Healthcare
AVAH
$2.67B
| $165K | ﹤0.01% |
31,825
+20,430
| +179% | +$92.4K |
2024 Q2
1 quarter
|
|
10354
PUT
Monte Rosa Therapeutics
GLUE
$880M
| $165K | ﹤0.01% |
31,200
+22,700
| +267% | +$115K |
2023 Q4
3 quarters
|
|
10355
CALL
Shinhan Financial Group
SHG
$35.4B
| $165K | ﹤0.01% |
3,900
+900
| +30% | +$36.8K |
2024 Q1
2 quarters
|
|
10356
PUT
America Movil
AMX
$66.1B
| $165K | ﹤0.01% |
10,100
-4,000
| -28% | -$67.7K |
2022 Q4
7 quarters
|
|
10357
CALL
Conduent
CNDT
$244M
| $165K | ﹤0.01% |
41,000
+25,300
| +161% | +$92.8K |
2017 Q1
30 quarters
|
|
|
ADVM
10358
DELISTED
Adverum Biotechnologies
ADVM
| $165K | ﹤0.01% |
23,534
-102,256
| -81% | -$743K |
2024 Q2
1 quarter
|
|
10359
CALL
Greenlight Captial
GLRE
$489M
| $165K | ﹤0.01% |
12,100
+3,200
| +36% | +$42.7K |
2023 Q4
3 quarters
|
|
|
CWEN.A
10360
CALL
DELISTED
Clearway Energy Class A
CWEN.A
| $165K | ﹤0.01% |
5,800
-7,200
| -55% | -$184K |
2022 Q1
10 quarters
|
|
10361
CALL
VanEck Merk Gold Trust
OUNZ
$2.67B
| $165K | ﹤0.01% |
6,500
-700
| -10% | -$16.7K |
2022 Q4
7 quarters
|
|
10362
PUT
Wabash National
WNC
$546M
| $165K | ﹤0.01% |
8,600
+1,300
| +18% | +$26.1K |
2022 Q4
7 quarters
|
|
10363
ProShares UltraShort Semiconductors
SSG
$35.4M
| $165K | ﹤0.01% |
+1,279
| New | +$194K |
2024 Q3
0 quarters
|
|
10364
PUT
Kimco Realty
KIM
$14.8B
| $165K | ﹤0.01% |
7,100
-18,900
| -73% | -$417K |
2022 Q2
9 quarters
|
|
10365
CALL
Mitek Systems
MITK
$770M
| $165K | ﹤0.01% |
19,000
-39,100
| -67% | -$396K |
2022 Q4
7 quarters
|
|
|
ME
10366
DELISTED
23andMe Holding Co
ME
| $165K | ﹤0.01% |
23,699
+17,428
| +278% | +$130K |
2023 Q2
5 quarters
|
|
10367
PUT
Regenxbio
RGNX
$534M
| $165K | ﹤0.01% |
15,700
+6,400
| +69% | +$78K |
2022 Q4
7 quarters
|
|
10368
PUT
Cohu
COHU
$3.24B
| $164K | ﹤0.01% |
6,400
+3,800
| +146% | +$106K |
2022 Q4
7 quarters
|
|
|
NB
10369
NioCorp Developments
NB
$497M
| $164K | ﹤0.01% |
75,332
+68,204
| +957% | +$125K |
2024 Q2
1 quarter
|
|
10370
Heritage Global
HGBL
$44.3M
| $164K | ﹤0.01% |
96,534
+70,921
| +277% | +$145K |
2022 Q4
7 quarters
|
|
10371
PUT
Invesco KBW Bank ETF
KBWB
$6.2B
| $164K | ﹤0.01% |
2,800
-1,800
| -39% | -$102K |
2022 Q3
8 quarters
|
|
10372
PUT
Alkami Technology
ALKT
$1.53B
| $164K | ﹤0.01% |
5,200
-16,100
| -76% | -$508K |
2022 Q4
7 quarters
|
|
|
SPNS
10373
CALL
DELISTED
Sapiens International
SPNS
| $164K | ﹤0.01% |
4,400
-300
| -6% | -$10.9K |
2022 Q1
10 quarters
|
|
10374
PUT
Relmada Therapeutics
RLMD
$338M
| $164K | ﹤0.01% |
50,600
+22,400
| +79% | +$72.5K |
2021 Q1
14 quarters
|
|
10375
Invesco MSCI Global Timber ETF
CUT
$28.8M
| $164K | ﹤0.01% |
+4,576
| New | +$154K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.